How much does Cemiplimab cost?

Cemiplimab (Cemiplimab) is an immune checkpoint inhibitor used to treat certain types of cancer. It is a monoclonal antibody designed to block the PD-1 receptor in the immune system, thereby enhancing the immune system's attack on cancer cells. Cimepilimab is not currently available in China, so patients cannot purchase it domestically and need to purchase cimepilimab through overseas channels. There are only cimepri monoclonal original drugs abroad, mainly European and American versions. The European version is about 40,000, and the American version is about 100,000. Both are original drugs, and their drug ingredients and efficacy are the same.